Status:
RECRUITING
Renal Physiology During Continuous Renal Replacement Therapy
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
AKI
Continuous Renal Replacement Therapy
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Approximately 50% of patients in the intensive care unit (ICU) develop acute kidney injury (AKI) and more than 10% need dialysis. There is no treatment for AKI. Care is aiming for optimization of circ...
Eligibility Criteria
Inclusion
- AKI, according to KDIGO, stage 2 or 3 but with preserved urine production. Treated in the ICU at Sahlgrenska University Hospital Written, signed informed consent Male and female subjects ≥18 years
Exclusion
- Emergency need for dialysis Allergy to contrast media (used for CEUS)
Key Trial Info
Start Date :
November 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04114747
Start Date
November 20 2020
End Date
December 31 2025
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 41345